Luc J. Farmer,Robert B. Perni,Govinda Rao Bhisetti,Keith P. Wilson
申请号：
US13238386
公开号：
US20120014914A1
申请日:
2011.09.21
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to compounds of formula I:or a pharmaceutically acceptable salt, or mixtures thereof, that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are useful as antiviral agents. The invention further relates to pharmaceutically acceptable compositions comprising said compounds either for ex vivo use or for administration to a patient suffering from HCV infection and processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a pharmaceutical composition comprising a compound of this invention.
